The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Colvin Paul since year 2005.
The trader's CIK number is 1513900.
At the time of this reporting, Colvin Paul is the EVP--Clinical Development of Pharmaceutical Product Development Inc .
(stock ticker symbol PPDI).
See this page for all insider trading activities at Pharmaceutical Product Development Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2011-05-27||PPDI||Pharmaceutical Product Development Inc||Sale||5,659||28.70||162,413|
|2011-05-26||PPDI||Pharmaceutical Product Development Inc||Sale||100||28.70||2,870|
|2011-05-27||PPDI||Pharmaceutical Product Development Inc||Option Ex||5,659||20.20||114,283|
|2011-05-26||PPDI||Pharmaceutical Product Development Inc||Option Ex||100||19.94||1,994|
|2011-05-20||PPDI||Pharmaceutical Product Development Inc||Sale||600||29.01||17,406|
|2011-05-20||PPDI||Pharmaceutical Product Development Inc||Option Ex||600||20.20||12,117|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Colvin Paul (EVP--Clinical Development of Pharmaceutical Product Development Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.